(Written by guest contributor Kevin E. Houchin Esq.) Last week we talked about the importance of understanding the various aspects of business formation and patents. This week we cover copyrights and trademarks. Continue Reading

Let me get right to the point. The reason our economy is in the tank today is that too many people are focused on creating money instead of creating real products and services. To correct this problem, we need to get back to the basics of creating products and services that people need or want, and let the money come as a result. That's the business of creativity, and it's going to be the... Continue Reading

A long time ago in galaxy far, far away, a thirteen-year old boy discovered a new world of action and adventure which had captured his imagination unlike anything before. Star Wars hit the theaters in 1977, and I still remember sitting in the very front row, completely in awe by the images on the screen. I probably saw the film ten times in our local cinema, and waited patiently for George Lucas to churn out... Continue Reading

Galoshes. Mukluks. Gazeebo. Macadamia. Blubber. Baluga. When you read those words, you either know what I am talking about and are busting out laughing, or you think I am totally insane and should be committed (well, you may be right on both counts). Continue Reading

It is with much fondness that I bid adieu to World of Warcraft. I've been playing my character, Riathamus, for just over a month, and I have experienced a great deal of what the game has to offer. However, the game is so enormous, so huge, and so seemingly endless, that I am in turning in my two-handed mace and calling it quits. This game is simply too good. It's too beautiful. It's too much... Continue Reading

Look out folks, another anti-arthritis drug has been linked to cardiovascular problems. Pfizer says a new study found an increased risk of heart problems with the painkiller Celebrex. Last month, Vioxx was withdrawn from the market. You know what this means, doncha? Unleash the ambulence chasers! The sue-happy attorneys now have more red meat with which to deepen their pockets and chase the price of medical care and drugs higher and higher. Essentially, the study... Continue Reading

And so, the litigation hounds once again are unleashed on the prescription drug community. This time it is over Vioxx, an anti-arthitic drug manufactured by Merck. Research has long pointed to the fact that long-term use of Vioxx may contribute to heart attacks and strokes. Perhaps the FDA didn't study the drug long enough. Perhaps the pharmaceutical companies are only interested in money. Perhaps people don't read the warning labels. And perhaps some were willing... Continue Reading